Search results
Results from the WOW.Com Content Network
The NASDAQ Biotechnology Index is a stock market index made up of securities of NASDAQ-listed companies classified according to the Industry Classification Benchmark as either the Biotechnology or the Pharmaceutical industry. [1] A list of the 225 components of the index is published online.
Drugs or medicines may be withdrawn from commercial markets because of risks to patients, but also because of commercial reasons (e.g. lack of demand and relatively high production costs).
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
OTCM QX ADR 30 Index; S&P Global 100; ... All Share Price Index (ASPI) Milanka Price Index ... Yahoo! Finance This page was ...
The index represents the biggest and most liquid stocks traded in individual countries. It was created by Dow Jones Indexes to reflect the globalization of international blue chip securities in the wake of mergers and the creation of megacorporations. The DJ Global Titans 50 is part of the Dow Jones Global Titans Indexes.
On July 17, 1995, the index closed above 1,000 for the first time. [8] Between 1995 and 2000, the peak of the dot-com bubble, the Nasdaq Composite stock market index rose 400%. It reached a price–earnings ratio of 200, dwarfing the peak price–earnings ratio of 80 for the Japanese Nikkei 225 during the Japanese asset price bubble of 1991. [9]
Map of all countries in the S&P 1200 as of Jan 21, 2019. The S&P Global 1200 Index is a free-float weighted stock market index of global equities from Standard & Poor's.The index was launched on Sep 30, 1999 and covers 31 countries and approximately 70 percent of global stock market capitalization. [1]